Epinephrine Acid Tartrate: Product Guide, Physical Properties, Safety, and Use

What Is Epinephrine Acid Tartrate?

Epinephrine Acid Tartrate stands out as a solid chemical raw material shaped from the combination of epinephrine, a well-known catecholamine neurotransmitter, and tartaric acid, a tartaric acid salt. This salt offers a unique profile, both in pharmacy and laboratory uses, and shows up on supply lists in the form of crystalline flakes, powders, or occasionally tiny pearls. The chemical formula reads C13H19NO9, with a molecular weight landing around 349.29 g/mol. Each molecule weaves together the catecholamine backbone with tartrate, producing a stable, manageable product for sensitive operations. For regulatory and shipping reasons, its HS Code commonly sits in the 2922 series, assigned for amino-alcohol and amino-acid derivatives. From a hands-on perspective, Epinephrine Acid Tartrate usually appears as a white to off-white crystalline solid with a fine, powder-like feel, sometimes developing as chunkier flakes or shining crystals depending on the batch’s growth conditions. Most commercial samples reveal a bulk density in the range of 0.45–0.65 g/cm³, though actual packing often pushes this number up or down based on how it has been processed or handled.

Physical and Chemical Properties

The appearance of Epinephrine Acid Tartrate hints at both purity and careful isolation, showing a visually pure texture. The solid form melts in the range of 95–100°C, which means it holds up under mild heat but won’t withstand flames or sterilizers running much hotter. Exposure to air and moisture can prompt slow darkening, a telltale oxidation sign, so it asks for dry, sealed containers and storage away from sunlight. In water, this material dissolves readily, forming clear or slightly cloudy solutions at room temperature. In strong acids or bases, some breakdown occurs, but daily lab solutions work fine at neutral or slightly acidic pH levels. Epinephrine Acid Tartrate acts both as a moderate reducing agent and holds delicate sensitivity to light and oxygen, not unusual for catecholamine salts. On the chemical side, each molecule intertwines the adrenaline structure with a tartrate, allowing relatively mild handling and mixing. I have seen labs keep backup vials refrigerated or frozen, both to steady chemical activity and to prevent oxidation.

Material Use, Applications, and Handling

Most demand for Epinephrine Acid Tartrate traces back to its use as an active pharmaceutical ingredient, both for injections and topical solutions. Proper mixing with other solvents and diluents lets medical producers control dosage down to the microgram, a must for safety and effectiveness. In pharmaceutical blending, consistency in the crystal shape, density, and purity stand at the top of the checklist. Research applications include enzyme assays, bioassays, and reference standards, with chemists often dissolving measured amounts in buffered water for short-term use. Packaging sizes can run from grams for lab testing to multi-kilogram drums for pharmaceutical production, always provided with detailed analysis certificates and specification sheets. No matter the use, users must check purity, water content, and stability—just one way the industry keeps bad lots from leaking into sensitive medical supply chains.

Safety, Hazards, and Environmental Concerns

Handling Epinephrine Acid Tartrate brings some familiar risks for chemical workers and clinicians. Direct skin contact, inhalation of dust, or accidental ingestion triggers acute responses, sometimes inducing rapid heartbeat, high blood pressure, or tremors. Though most powders stay stable in storage, open containers invite humidity and air, prompting partial oxidation that can affect both chemical activity and safety. Experienced chemists work under chemical fume hoods, use nitrile gloves, and wear tight-sealing goggles while weighing out material or making solutions. Safe disposal depends on local rules: most sites collect excess solid or spent solutions as hazardous pharmaceutical waste, never pouring down ordinary sinks. MSDS sheets spell out specific first-aid steps in case of exposure—this chemical ranks as hazardous, not just harmful, and needs respect even in small laboratory batches. Any spills on surfaces should be cleaned up using minimal dry absorbent and copious rinsing, always with full personal protective gear.

Solutions for Safer and Smarter Handling

With all the complexity of modern chemistry and drug manufacturing, smart risk reduction makes a real difference. Storing Epinephrine Acid Tartrate in amber bottles or tightly sealed containers, away from both sunlight and humidity, reduces spoilage and toxic breakdown. Timely monitoring of solution color warns of slow oxidation, signaling a need for replacement before a batch flunks quality control. Automated dispensing equipment can cut down dust in air, protecting both product and technician. Where large-scale operations take place, rigorous staff training and investment in local exhaust ventilation keeps labs safe from accidental poisoning or cross-contamination. As demand for safe, high-efficacy pharmaceuticals rises, strict regulatory reporting ensures only properly handled product enters the medical supply chain. Forward-looking companies now adopt real-time stock tracking and cold-chain options for their most sensitive materials, proving that both profit and public welfare benefit directly from higher safety standards.

Specifications and Regulatory Data

Trust in Epinephrine Acid Tartrate rests on careful documentation. Every lot should come with clear specifications: chemical formula (C13H19NO9), precise molecular weight (349.29 g/mol), appearance (white to off-white solid, flake, powder, or crystal), purity (usually not less than 98%), density (measured in laboratory conditions), solubility profile (freely soluble in water, unstable in strong acid), melting point (95–100°C), and a matching HS Code for customs. Reputable suppliers offer COAs with each batch, giving pharmaceutical clients and research teams confidence they know what they are buying and how to handle possible risks. Right now, regulators expect prompt disclosure of both safe and harmful properties, including hazardous byproducts and proper disposal routes. That level of transparency helps the entire industry level up and protect staff, patients, and the wider environment.